Alamar Biosciences, Inc. (ALMR) Institutional Ownership & Insider Trading
86 institutions reported holding Alamar Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 54 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · read by EquiReason
ALMRAlamar Biosciences, Inc.Follow ALMR — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters86 institutions held 35.1% of the shares. Across filers that reported both quarters, shares held changed —.
Largest moves, shares (millions)
Alamar Biosciences, Inc. — questions
- Who owns Alamar Biosciences, Inc. stock?
- 86 institutions reported Alamar Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Sands Capital Alternatives, LLC (6.1%), SAMSARA BIOCAPITAL, LLC (3.6%), T. Rowe Price Investment Management, Inc. (3.2%).
- Are Alamar Biosciences, Inc. insiders buying or selling?
- 54 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Alamar Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.